Pharma BD Deal Intelligence

Sanofi SA / Bioverativ Inc.

2018 · Acquisition/Merger · $11.6B · Complete

Announcement Sentiment

63

Positive

Outcome Score

56

Mixed — partial payoff, real shortfalls.

Sanofi acquired Bioverativ for $11.6B for hemophilia treatment.

Key facts

Announced Jan 22, 2018
Closed Mar 08, 2018
Deal value $11.6B
Deal type Acquisition/Merger
Therapeutic area Hematology

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals